Diabetes
Innovent Biologics gets FDA nod to begin Phase 1 trials of oral GLP-1R agonist IBI3032
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
August 05, 2025 | News
Fangzhou and Novo Nordisk Forge Strategic Alliance to Revolutionise Chronic Disease Management with AI
Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, ...
July 21, 2025 | News
Ascletis Completes Dosing in U.S. Trial of ASC47 and Semaglutide for Obesity
The combination study, conducted in the U.S., is designed to evaluate the safety, tolerability and preliminary efficacy at Day ...
July 15, 2025 | News
Amarna Therapeutics and NorthX Biologics Advance Nimvec™ AM510 Toward Clinical Trials for Type 1 Diabetes
Fast-Tracking Clinical Readiness: The agreement enables process and analytical development activities required to advance Nimvec™ AM510 for Type 1 ...
July 14, 2025 | News
Silo Pharma and Hoth Therapeutics to Jointly Develop VA-Invented Biologic for Obesity and Metabolic Disorders
Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therap...
June 26, 2025 | News
Eluminex Reports Positive Phase 1 Results for EB-105 in Diabetic Macular Edema Patients
EB-105 Targets VEGF-A, -B, PlGF, Ang-2, and IL-6R Improvements in Visual Acuity and Retinal Edema Observed at All Dose Levels No Safety Issues Observed...
June 10, 2025 | News
Zuellig Pharma to Launch Eli Lilly’s Mounjaro® in Thailand to Address Growing Obesity and Diabetes Burden
Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro® (tirzepatide), the innovative obesity and diabetes me...
May 27, 2025 | News
Ascletis’ ASC30 SQ Injection Shows 36-Day Half-Life in Phase Ib Obesity Trial
-Ultra-long-acting subcutaneous (SQ) injection formulation of small molecule ASC30 demonstrated a 36-day half-life in patients with obesity, supp...
April 01, 2025 | News
Singapore’s NUS Researchers Develop Dual Microneedle Technologies to Accelerate Healing of Diabetic Wounds
Diabetic wounds often lead to severe complications that can result in amputations. These chronic and non-healing wounds are marked by persistent inflammati...
March 27, 2025 | News
MicuRx’s MRX-4 and Contezolid Show Favorable Safety and Efficacy in Phase III Trial for Diabetic Foot Infections
Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial, recommending continued pro...
February 26, 2025 | News
BioMed X Launches Research Hub in Barbados to Advance Cardiometabolic Disease Treatment for Individuals of African Descent
BioMed X Institute, in collaboration with the Government of Barbados and the European Commission, is launching BioMed X Barbados, a new rese...
February 21, 2025 | News
ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
With obesity-related chronic diseases on the rise in Singapore, ORA Group has introduced a pioneering hybrid weight management model, blend...
February 19, 2025 | Expert Insight
ORA Group Introduces Singapore’s First Hybrid Weight Management Care to Tackle Rising Obesity Rates
ORA Group (ORA), a leading Singapore-based health and wellness company known for its cutting-edge telehealth platforms andSons and OVA, has unveiled a grou...
February 12, 2025 | News
Genentech Secures FDA Approval for Susvimo the First Long-Lasting Treatment for Diabetic Macular Edema
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME...
February 05, 2025 | News
Most Read
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
